Team

Board

Luis Claudio Garcia de Souza

Co-Founder and Chairman

Luis Claudio Garcia de Souza

Co-Founder and Chairman

Civil Engineering from PUC-Rio, Master's in Systems and Transportation Engineering, MIT. Founder and Chairman of Finvest, Chairman of Captalys. Founded and built RB Capital, Rio Bravo Investimentos and UBF Seguros. Executive Committee of Banco Pactual, Board Member, BOVESPA. Advisory Board of Securitas Capital, PE arm of Swiss Re

Martha Farmer, PhD

Board member and Chairman Advisory Board

Martha Farmer, PhD

Board member and Chairman Advisory Board

Co-Founder and CEO (retired) of North Shore InnoVentures, a biotech/cleantech incubator in Boston that has fostered 60 startups. Previously with Baxter Healthcare, Hemoglobin Therapeutics division. Dr. Farmer serves on several company and non-profit boards and is a member of e-Coast Angels. BSc and PhD from Duke University, postdoc at Johns Hopkins, and a Medical Ethics Fellow at Harvard University. 30 publications and 3 patents.

Adriana Machado

Advisory Board member

Adriana Machado

Advisory Board member

Political Science from UnB and an outspoken advocate of the impact economy. Founder of the Briyah Institute, Miami. Mrs. Machado serves on several boards, and is a strategic partner at WOMB Group. First woman President & CEO of GE Brazil, Government Affairs & Policy for GE Latin America. Intel Brazil, Amcham-SP, and US Embassy in Brasilia.

Shawn G. Bengtson, RQAP-GLP

Quality Assurance Advisor

Shawn G. Bengtson, RQAP-GLP

Quality Assurance Advisor

Director of Quality Assurance, Quality Systems Management and Research Operations Management at the University of Pittsburgh. Former National Aeronautics Space Administration (NASA) Life Sciences Division.

Management

Matias Vidal

Co-Founder and CEO

Matias Vidal

Co-Founder and CEO

Bsc. In Economics, Universidad Católica Argentina. Partner, Finvest Group, oversees investments in Biotech and Healthcare through Securitas Biosciences Group, a venture building fund. Mr. Vidal led the formation and organization of Securitas Biosciences and attracted key human resources; a diverse interdisciplinary group of scientists, doctors and executives. In 2013, co-founded Finvest’s group first initiative in the biotech sector, VirTech Bio, and led the company as CEO until August 2019. He is acting CEO of Vaxinz, a biotech start-up that specializes in the design and development of novel vaccines targeting human emerging infectious diseases. He serves as Board member and Executive Chairman of several portfolio companies, VirTech Bio, TheraVax, Meton, OCC Biotech and HZ4 Liver. He has an extensive international career, with over 25 years experience in consulting, Investment Banking, M&A, and portfolio management. Former Cooper&Lybrand, Deutsche Morgan Grenfell, Dresdner Kleinwort Wasserstein

Julián Maggini, MD, PhD

CSO

Julián Maggini, MD, PhD

CSO

Juián Maggini is an MD PhD from the University of Buenos Aires, Argentina. Dr. Maggini has specialized in internal medicine at the Austral University Hospital and completed his doctoral thesis at the National Academy of Medicine studying the immunological role of mesenchymal stem cells. He has collaborated in the foundation of the cell culture platform in the Department of Pharmacology of the Faculty of Medicine, University of Buenos Aires. He participated in the creation of the General Direction of Science and Technology Policy Management in the City of Buenos Aires, as an advisor to the General Director. He also worked as Medical Director of the Laboratorio Internacional Argentino and Abbott EPD. Since 2015, Dr. Maggini is the Director of the Technology Transfer Office of the Austral University, which articulates the University, the University Hospital and the Austral Technology Business Park - based companies to promote scientific projects of high impact. The strategy of the TTO is to develop demand-oriented Science & Technology platforms, working collaboratively with technology-based companies as strategic partners. We aim to achieve the sustainability of our R&D portfolio and create an innovation ecosystem based on scientific knowledge.

Augusto Carvalho

Chief Financial Officer

Augusto Carvalho

Chief Financial Officer

Senior Analyst at Finvest, responsible for leading the market analysis and the identification of investment opportunities. Responsible for developing a platform thesis for regional healthcare networks (encompassing hospitals, specialized clinics and adjacent business opportunities) in Brazil as well as monitoring and providing management support to portfolio companies. Augusto holds a M.Sc. in Economics from Sao Paulo School of Economics (FGV), B.S. in Economics from the same institution and a B.S. in Physics from USP.

Filipe Vasconcelos

Finance Analyst

Filipe Vasconcelos

Finance Analyst

Senior Analyst at Finvest, specializing in financial analysis and budget forecasting. Leads competitive and market analysis to monitor industry trends and assess competitors. Brings extensive experience in Brazil's public sector, spanning both executive and legislative branches. Holds a Master’s degree in Economics from the University of São Paulo (USP) and a Bachelor’s degree in Economics from the Federal University of Pernambuco (UFPE).

Nicolás Kitashima

VP of Operations Latam

Nicolás Kitashima

VP of Operations Latam

B.S. in Administration from University of Buenos Aires. Attend M.Sc. In data science Austral University.Operations Director of the Institute of Applied Artificial Intelligence and member of Technology Transfer, Universidad Austral.

Maximiliano Sanchez Lamas, PhD

Chief technology officer

Maximiliano Sanchez Lamas, PhD

Chief technology officer

PhD in Biological Sciences with 11+ years research experience and translational biotechnology applications. Carried out his research at the Molecular Biology Lab at Fundación Instituto Leloir. Areas of research include Molecular Biology, Plant Biology, and Eukaryots Biotechnology. Proficient in experimental design, DNA construction design and assembly, transgenesis, RNA and protein expression assays, Chemical screenings in biologic systems, statistical analysis, and biological interpretation.

Victoria Sundblad, PhD

VP R&D

Victoria Sundblad, PhD

VP R&D

Victoria Sundblad, MSc., PhD. She graduated from the University of Buenos Aires (2000) and has a PhD in Biological Chemistry from the same University (2005). She has more than 20 years of experience in basic biomedical research at CONICET, in the field of molecular endocrinology and immunology. Convinced of the richness of interdisciplinary work and with great ability to alchemize different points of view, she promoted and participated in numerous collaborative projects seeking to contribute to bridging the gap between knowledge and improvement of human health.

Mariano Salibe, PhD

VP R&D

Mariano Salibe, PhD

VP R&D

B.s Biology Universidad de Buenos Aires (UBA), Argentina PhD in Biology UBA in partnership with Instituto Leloir, Invited Investigator at Cornell University Medical School, NY Senior Investigator at Gentron Inc, Medical Lead at Novartis Argentina for Psoriasis, Autoinflammatory diseases and transplants

Ventura Simonovich, MD

Clinical Pharmacology VP

Ventura Simonovich, MD

Clinical Pharmacology VP

Medical doctor graduated from the University of Buenos Aires (1995) with a specialization in internal medicine and clinical pharmacology. He has been department director and full professor of Human Physiology and currently full professor of the research department at the University Institute of the Italian Hospital of Buenos Aires. He has been a consultant on drug policies for the United Nations and on research management for the Pan American Health Organization. He currently serves as Head of the Clinical Pharmacology Section and Coordinator of the Research Department of the Italian Hospital of Buenos Aires. His area of expertise is clinical studies, particularly phase 1 (first in human).

Paula Berguer, PhD

Pre-Clinical VP

Paula Berguer, PhD

Pre-Clinical VP

B.s Biology at Universidad de Buenos Aires (UBA), Argentina. PhD in Biological Sciences, UBA. Associate Investigator at Molecular Immunology and Microbiology Lab at Fundación Instituto Leloir. Research experience in experimental immunology, molecular biology, cell culture and preclinical studies.

Mariano Núñez, MD

Medical and Pharmacology Advisor

Mariano Núñez, MD

Medical and Pharmacology Advisor

Mariano Nuñez, is an MD graduated from the University of Buenos Aires, Argentina. He has specialized in Internal Medicine and Pharmacology. He is currently Professor of Pharmacology at the University of Buenos Aires and Director of Pharmacovigilance at the Institute of Pharmacology, School of Medicine, University of Buenos Aires. He has worked as an advisor in the Ministry of Health of Argentina, and has worked as a scientific director in pharmaceutical companies. He is currently general manager of Tecnología Innovativa, a company dedicated to providing global business development services to the pharmaceutical industry, and has participated in the development of several cooperation agreements between global and local companies for business and project development.

Paula Scibona, MD

Clinical Pharmacology Advisor

Paula Scibona, MD

Clinical Pharmacology Advisor

Medical doctor graduated from the University of Buenos Aires (2004) with a specialization in internal medicine and clinical pharmacology. She currently serves as Staff of the Clinical Pharmacology Section and Member of the Institutional Review Board at the Italian Hospital of Buenos Aires. Professor at the University Institute of the Italian Hospital of Buenos Aires, Member of the Research Council and the Institutional Innovation Council at the Italian Hospital of Buenos Aires. Member of Translational Health Research Network (RITS) of CONICET Her area of expertise is translational medicine, clinical studies, particularly early phases

Gabriela Sycz, PhD

Scientific Analyst

Gabriela Sycz, PhD

Scientific Analyst

PhD in Biological Sciences (UBA) with 17+ years of research experience in Molecular Biology and Microbiology. Worked at Fundación Instituto Leloir, Washington University in St. Louis, and the University of Pittsburgh, USA. Areas of research include Molecular Biology, Microbiology, Bacterial Pathogenesis (BSL-3), Cell-culture, DNA construction design and assembly, RNA and protein expression assays, Protein Purification and protein-protein interactions, Fluorescence microscopy. 13 years of teaching (UBA) and mentoring.

Mariela Bollini, PhD

VP Medicinal Chemistry

Mariela Bollini, PhD

VP Medicinal Chemistry

Dr. Mariela Bollini is a Biochemist and Pharmacist who earned both her undergraduate degree and Ph.D. in Medicinal Chemistry from the University of Buenos Aires, completing her doctorate in 2009. She then pursued a postdoctoral fellowship at Yale University, where she specialized in Computer-Aided Drug Discovery and Medicinal Chemistry. In 2013, she joined the CONICET Investigator Career and is now an Independent Investigator. She serves as Vice-Director of the Center for Bionanoscience Research (CIBION) and leads the Medicinal Chemistry Laboratory at CONICET. Her research focuses on developing antiviral entry inhibitors against a range of viruses, including dengue, Zika, bovine viral diarrhea, and chikungunya.

Brian Reznik, Engr.

Investor Relations

Brian Reznik, Engr.

Investor Relations

Brian is a highly accomplished Chemical Engineer with a strong focus on business development and innovation. As a Founder and business development manager, he has a passion for creating innovative solutions that lead to growth and success. Throughout his career, Brian has demonstrated a knack for identifying new opportunities, forming strategic partnerships, and implementing effective marketing strategies. His expertise extends to both general management and business development, making him a well-rounded professional ready to take on new challenges. Brian has a track record of leading and growing businesses, ranging from multinational companies (Tolsa, Imdex LImited) to venture capital-backed startups (Nanotransfer).

Nicolas Ruarte

Operations and multimedia design

Nicolas Ruarte

Operations and multimedia design

Nicolás Ruarte is a multimedia artist and designer. He works as a consultant in multimedia design and AI development for several leading companies in the field. He's also a college professor and researcher specialized in AI, 3D animation, UX/UI design and audiovisual production. He is a BA in Visual Arts at UNA with a specialization in Image Digitization. He’s the CEO of NoMa Studio AI the first AI design and animation studio of Argentina specialized in AI solutions for creative industries. He obtained the Huawei HCIA - Artificial Intelligence Certification in 2023 through a scholarship from the “1000 Talents for Digital Development” program. He specializes in AI tool development, image and sound generation, and prompt engineering. As an assistant researcher at UNA, he works in BioArt and Visual Arts Technology teams. Since 2015, he has worked as a 3D modeler, photographer, and audiovisual producer for clients like the Ministry of National Transportation. His short film "(0,0)" won awards at SWIFF and Girona Film Festival, and he has directed multiple theater and film projects.